Advanced Medical Solutions Group (LON:AMS) Stock Passes Above 200 Day Moving Average – What’s Next?

Advanced Medical Solutions Group plc (LON:AMS)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 215 and traded as high as GBX 247.50. Advanced Medical Solutions Group shares last traded at GBX 245.34, with a volume of 745,721 shares traded.

Analyst Ratings Changes

Several research analysts recently issued reports on AMS shares. Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 270.25.

Advanced Medical Solutions Group Stock Performance

The firm has a market capitalization of £534.52 million, a P/E ratio of 54.65, a price-to-earnings-growth ratio of 5.00 and a beta of 0.63. The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50. The company has a 50-day moving average of GBX 212.71 and a 200-day moving average of GBX 215.

Advanced Medical Solutions Group (LON:AMS) last announced its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. On average, equities analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.